Redica Systems

Conference Spotlight

Health Canada: Regulating and Overseeing Drug and Medical Device Manufacturers

April 30, 2024

Guarding Against Risk with Vendor Agreements

March 4, 2024

What Is Quality Intelligence? How is Data Governance a Key Enabler?

January 16, 2024

Farewell FDAzilla.com

January 8, 2024

At GMP by the Sea, Redica Systems Corroborates FDA Example on the Spot

November 8, 2023

Conference Spotlight

Looking Outside Your Four Walls at GMP by the Sea

November 1, 2023

Welcoming Roger Angarita as Redica Systems’ New Chief Product Officer

October 18, 2023

What is “Quality and Regulatory Intelligence”?

September 11, 2023

Trends

How Redica Systems Goes Further than the FDA Data Dashboard

August 21, 2023

Audience Q&A: From Legal Considerations when Interacting with the FDA Webinar

August 10, 2023

Legal Advice for Before, During, and After an FDA Inspection

July 25, 2023

Enforcement

Expert Commentary: FY2022 Report on the State of Pharmaceutical Quality

June 29, 2023

On-Demand Webinar: Insights on API Inspection Deficiencies

June 6, 2023

Peter Baker’s Roadmap to Quality Intelligence

June 1, 2023

On-Demand Webinar: Legal Considerations when Interacting with the FDA

May 9, 2023

Trends

Redica Responds: What are Common Laboratory Inspection Findings?

May 1, 2023

Audience Q&A: From Data Integrity and Quality Culture Webinar

April 3, 2023

Conference Spotlight

Is Raw FDA Data Skewing Your Analyses?

March 23, 2023